NRC:Improving Healthcare for Cognitively Impaired Elders and Their Caregivers



Status:Recruiting
Conditions:Alzheimer Disease
Therapuetic Areas:Neurology
Healthy:No
Age Range:Any
Updated:5/17/2018
Start Date:February 1, 2018
End Date:October 2018
Contact:Christine A Coulter, Ph.D.
Email:cac76@uw.edu
Phone:206-685-9169

Use our guide to learn which trials are right for you!

NRC: Improving Healthcare for Cognitively Impaired Elders and Their Caregivers

An multi-stage mixed-method design will be employed to obtain both qualitative and
quantitative data to address two study aims: (1) Evaluate and refine the delivery Reducing
Disabilities in Alzheimer's Disease (RD- AD) training to advanced practice nurses and (2)
Evaluate and refine the implementation of RD-AD by advanced practice nurses in their medical
settings.

Two waves of APNs (25 each wave/total 50) will receive RDAD training and be queried pre and
post- training using both qualitative and quantitative procedures to determine: (1) Is RDAD
training successfully received by advanced practice nurses? (2) Do they report it as relevant
to improving the care they deliver to persons with Alzheimer's Disease and Related Dementias
(ADRD)? (3) Does RDAD training of advanced practice nurses improve their level of knowledge
about ADRD, their skills in providing ADRD care, and their level of confidence in providing
this care?

A subset of advanced practice nurses (5 per wave, total of 10) will be recruited to implement
RDAD as part of their ongoing care of persons with ADRD.

Inclusion Criteria:

- Licensed by the Washington state Department of Health as an Advanced Registered Nurse
Practitioner (ARNP),

- Hold a board certification as a Gerontological Nurse Practitioner, Adult Nurse
Practitioner, or Family Nurse Practitioner,

- Work at least half time (0.50 FTE) in a clinical setting (primary care, internal
medicine, sub-specialty, medical home), with a panel consisting of over 25% of
patients over 65 years of age,

- Have no expectation for termination over the course of the study; and

- Agree to participate in all phases of the RDAD translational program.

Exclusion Criteria:
We found this trial at
1
site
Seattle, Washington 98104
(206) 543-2100
Principal Investigator: Linda Teri, Ph.D.
Phone: 206-616-5550
Univ of Washington Founded in 1861 by a private gift of 10 acres in what...
?
mi
from
Seattle, WA
Click here to add this to my saved trials